Thomas Brunner

Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12

Emmanouil Fokas, Michael Allgäuer, Bülent Polat et al. · Journal of Clinical Oncology · 2019 · 540 citations · Full text

Medicine, Oncology, Surgery +17

Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation

Emmanouil Fokas, Remko Prevo, John R. Pollard et al. · Cell Death and Disease · 2012 · 364 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer

Emmanouil Fokas, Anke Schlenska‐Lange, Bülent Polat et al. · JAMA Oncology · 2021 · 354 citations · Full text

Medicine, Surgery, Gastrointestinal Oncology +13

ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)

Jens Hoeppner, Florian Lordick, Thomas Brunner et al. · BMC Cancer · 2016 · 353 citations · Full text

Medicine, Oncology, Surgery +17

Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer

Henriette Golcher, Thomas Brunner, Helmut Witzigmann et al. · Strahlentherapie und Onkologie · 2014 · 330 citations · Full text

Medicine, Oncology, Surgery +17